» Articles » PMID: 36922433

Extracellular Vesicles from Hyperammonemic Rats Induce Neuroinflammation in Hippocampus and Impair Cognition in Control Rats

Overview
Publisher Springer
Specialty Biology
Date 2023 Mar 16
PMID 36922433
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with liver cirrhosis show hyperammonemia and peripheral inflammation and may show hepatic encephalopathy with cognitive impairment, reproduced by rats with chronic hyperammonemia. Peripheral inflammation induces neuroinflammation in hippocampus of hyperammonemic rats, altering neurotransmission and leading to cognitive impairment. Extracellular vesicles (EVs) may transmit pathological effects from the periphery to the brain. We hypothesized that EVs from peripheral blood would contribute to cognitive alterations in hyperammonemic rats. The aims were to assess whether EVs from plasma of hyperammonemic rats (HA-EVs) induce cognitive impairment and to identify the underlying mechanisms. Injection of HA-EVs impaired learning and memory, induced microglia and astrocytes activation and increased TNFα and IL-1β. Ex vivo incubation of hippocampal slices from control rats with HA-EVs reproduced these alterations. HA-EVs increased membrane expression of TNFR1, reduced membrane expression of TGFβR2 and Smad7 and IκBα levels and increased IκBα phosphorylation. This led to increased activation of NF-κB and IL-1β production, altering membrane expression of NR2B, GluA1 and GluA2 subunits, which would be responsible for cognitive impairment. All these effects of HA-EVs were prevented by blocking TNFα, indicating that they were mediated by enhanced activation of TNFR1 by TNFα. We show that these mechanisms are very different from those leading to motor incoordination, which is due to altered GABAergic neurotransmission in cerebellum. This demonstrates that peripheral EVs play a key role in the transmission of peripheral alterations to the brain in hyperammonemia and hepatic encephalopathy, inducing neuroinflammation and altering neurotransmission in hippocampus, which in turn is responsible for the cognitive deficits.

Citing Articles

Ammonia and beyond - biomarkers of hepatic encephalopathy.

Gallego J, Ballester M, Fiorillo A, Casanova-Ferrer F, Lopez-Gramaje A, Urios A Metab Brain Dis. 2025; 40(1):100.

PMID: 39812958 PMC: 11735499. DOI: 10.1007/s11011-024-01512-7.


Contribution of extracellular vesicles to neuroinflammation and cognitive and motor deficits in hyperammonemia and hepatic encephalopathy.

Izquierdo-Altarejos P, Felipo V Extracell Vesicles Circ Nucl Acids. 2024; 5(1):37-43.

PMID: 39698415 PMC: 11648396. DOI: 10.20517/evcna.2023.66.


Role of peripheral inflammation in minimal hepatic encephalopathy.

Llansola M, Izquierdo-Altarejos P, Montoliu C, Mincheva G, Palomares-Rodriguez A, Pedrosa M Metab Brain Dis. 2024; 39(8):1667-1677.

PMID: 39177864 DOI: 10.1007/s11011-024-01417-5.

References
1.
Kaji K, Saikawa S, Takaya H, Fujinaga Y, Furukawa M, Kitagawa K . Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients. Antibiotics (Basel). 2020; 9(4). PMC: 7235723. DOI: 10.3390/antibiotics9040145. View

2.
Connolly K, Wadey R, Mathew D, Johnson E, Aled Rees D, James P . Evidence for Adipocyte-Derived Extracellular Vesicles in the Human Circulation. Endocrinology. 2018; 159(9):3259-3267. PMC: 6109300. DOI: 10.1210/en.2018-00266. View

3.
Taoro-Gonzalez L, Cabrera-Pastor A, Sancho-Alonso M, Arenas Y, Meseguer-Estornell F, Balzano T . Differential role of interleukin-1β in neuroinflammation-induced impairment of spatial and nonspatial memory in hyperammonemic rats. FASEB J. 2019; 33(9):9913-9928. DOI: 10.1096/fj.201900230RR. View

4.
Selmaj I, Mycko M, Raine C, Selmaj K . The role of exosomes in CNS inflammation and their involvement in multiple sclerosis. J Neuroimmunol. 2017; 306:1-10. DOI: 10.1016/j.jneuroim.2017.02.002. View

5.
Magnani M, Crinelli R, Bianchi M, Antonelli A . The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Curr Drug Targets. 2001; 1(4):387-99. DOI: 10.2174/1389450003349056. View